{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T16:31:09Z","timestamp":1759422669226},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2015,3,14]],"date-time":"2015-03-14T00:00:00Z","timestamp":1426291200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["PharmacoEconomics"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1007\/s40273-015-0269-8","type":"journal-article","created":{"date-parts":[[2015,3,13]],"date-time":"2015-03-13T07:15:17Z","timestamp":1426230917000},"page":"521-531","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Cost-Utility Analysis of Intravenous Immunoglobulin for the Treatment of Steroid-Refractory Dermatomyositis in Thailand"],"prefix":"10.1007","volume":"33","author":[{"given":"Naruemon","family":"Bamrungsawad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathorn","family":"Chaiyakunapruk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nilawan","family":"Upakdee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chayanin","family":"Pratoomsoot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosarin","family":"Sruamsiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piyameth","family":"Dilokthornsakul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,3,14]]},"reference":[{"issue":"5","key":"269_CR1","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.clindermatol.2006.07.001","volume":"24","author":"JP Callen","year":"2006","unstructured":"Callen JP, Wortmann RL. Dermatomyositis. Clin Dermatol. 2006;24(5):363\u201373.","journal-title":"Clin Dermatol."},{"issue":"1","key":"269_CR2","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1001\/archdermatol.2009.328","volume":"146","author":"MJ Bendewald","year":"2010","unstructured":"Bendewald MJ, Wetter DA, Li X, Davis MD. Incidence of dermatomyositis and clinically amyopathic dermatomyositis: a population-based study in Olmsted County, Minnesota. Arch Dermatol. 2010;146(1):26\u201330.","journal-title":"Arch Dermatol."},{"issue":"5","key":"269_CR3","doi-asserted-by":"crossref","first-page":"A330","DOI":"10.1016\/j.autrev.2009.11.006","volume":"9","author":"S Prieto","year":"2010","unstructured":"Prieto S, Grau JM. The geoepidemiology of autoimmune muscle disease. Autoimmun Rev. 2010;9(5):A330\u20134.","journal-title":"Autoimmun Rev."},{"issue":"1","key":"269_CR4","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1001\/archdermatol.2009.328","volume":"146","author":"MJ Reeder","year":"2010","unstructured":"Reeder MJ, Wetter DA, Li X, Davis MDP. Incidence of dermatomyositis and clinically amyopathic dermatomyositis: a population-based study in Olmsted County, Minnesota. Arch Dermatol. 2010;146(1):26\u201330.","journal-title":"Arch Dermatol."},{"issue":"2","key":"269_CR5","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1756-185X.2010.01472.x","volume":"13","author":"S Cox","year":"2010","unstructured":"Cox S, Limaye V, Hill C, Blumbergs P, Roberts-Thomson P. Idiopathic inflammatory myopathies: diagnostic criteria, classification and epidemiological features. Int J Rheum Dis. 2010;13(2):117\u201324.","journal-title":"Int J Rheum Dis."},{"issue":"5","key":"269_CR6","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1002\/mus.23302","volume":"45","author":"DE Furst","year":"2012","unstructured":"Furst DE, Amato AA, Iorga \u015eR, Gajria K, Fernandes AW. Epidemiology of adult idiopathic inflammatory myopathies in a U.S. managed care plan. Muscle Nerve. 2012;45(5):676\u201383.","journal-title":"Muscle Nerve."},{"issue":"2","key":"269_CR7","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1479-8077.2007.00267.x","volume":"10","author":"V Limaye","year":"2007","unstructured":"Limaye V, Blumbergs P, Scott G, Hakendorf P, Roberts-Thomson PJ. The epidemiology of dermatomyositis in South Australia. APLAR J Rheum. 2007;10(2):94\u2013100.","journal-title":"APLAR J Rheum."},{"issue":"8","key":"269_CR8","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.3899\/jrheum.101002","volume":"38","author":"Y Yamasaki","year":"2011","unstructured":"Yamasaki Y, Yamada H, Ohkubo M, et al. Longterm survival and associated risk factors in patients with adult-onset idiopathic inflammatory myopathies and amyopathic dermatomyositis: experience in a single institute in Japan. J Rheumatol. 2011;38(8):1636\u201343.","journal-title":"J Rheumatol."},{"issue":"9388","key":"269_CR9","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(03)14368-1","volume":"362","author":"MC Dalakas","year":"2003","unstructured":"Dalakas MC, Hohlfeld R. Polymyositis and dermatomyositis. Lancet. 2003;362(9388):971\u201382.","journal-title":"Lancet."},{"issue":"1","key":"269_CR10","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.autrev.2011.06.007","volume":"11","author":"I Marie","year":"2011","unstructured":"Marie I, Mouthon L. Therapy of polymyositis and dermatomyositis. Autoimmun Rev. 2011;11(1):6\u201313.","journal-title":"Autoimmun Rev."},{"issue":"6","key":"269_CR11","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1056\/NEJM199202063260602","volume":"326","author":"B Sigurgeirsson","year":"1992","unstructured":"Sigurgeirsson B, Lindelof B, Edhag O, Allander E. Risk of cancer in patients with dermatomyositis or polymyositis. A population-based study. N Engl J Med. 1992;326(6):363\u20137.","journal-title":"N Engl J Med."},{"key":"269_CR12","first-page":"2696","volume-title":"Harrison\u2019s principles of internal medicine","author":"MC Dalakas","year":"2008","unstructured":"Dalakas MC. Polymyositis, dermatomyositis and inclusion body myositis. In: Kasper DL, Braunwald E, Fauci AS, et al., editors. Harrison\u2019s principles of internal medicine. 17th ed. New York: McGraw-Hill; 2008. p. 2696\u2013703.","edition":"17"},{"issue":"3","key":"269_CR13","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/nrrheum.2010.2","volume":"6","author":"MC Dalakas","year":"2010","unstructured":"Dalakas MC. Immunotherapy of myositis: issues, concerns and future prospects. Nat Rev Rheumatol. 2010;6(3):129\u201337.","journal-title":"Nat Rev Rheumatol."},{"issue":"5","key":"269_CR14","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/WCO.0b013e32834a9589","volume":"24","author":"MC Dalakas","year":"2011","unstructured":"Dalakas MC. Inflammatory myopathies: management of steroid resistance. Curr Opin Neurol. 2011;24(5):457\u201362.","journal-title":"Curr Opin Neurol."},{"issue":"3","key":"269_CR15","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s11940-011-0119-8","volume":"13","author":"MC Dalakas","year":"2011","unstructured":"Dalakas MC. Immunotherapy of inflammatory myopathies: practical approach and future prospects. Curr Treat Options Neurol. 2011;13(3):311\u201323.","journal-title":"Curr Treat Options Neurol."},{"issue":"3","key":"269_CR16","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1177\/1756285608097463","volume":"1","author":"MC Dalakas","year":"2008","unstructured":"Dalakas MC. Therapeutic advances and future prospects in immune-mediated inflammatory myopathies. Ther Adv Neurol Disord. 2008;1(3):157\u201366.","journal-title":"Ther Adv Neurol Disord."},{"issue":"1","key":"269_CR17","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2165\/00003495-199754010-00003","volume":"54","author":"P Cherin","year":"1997","unstructured":"Cherin P. Recognition and management of myositis. Drugs. 1997;54(1):39\u201349.","journal-title":"Drugs."},{"issue":"4","key":"269_CR18","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.nmd.2005.12.008","volume":"16","author":"MC Dalakas","year":"2006","unstructured":"Dalakas MC. Therapeutic targets in patients with inflammatory myopathies: present approaches and a look to the future. Neuromuscul Disord. 2006;16(4):223\u201336.","journal-title":"Neuromuscul Disord."},{"issue":"27","key":"269_CR19","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1056\/NEJM199312303292704","volume":"329","author":"MC Dalakas","year":"1993","unstructured":"Dalakas MC, Illa I, Dambrosia JM, et al. A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis. N Engl J Med. 1993;329(27):1993\u20132000.","journal-title":"N Engl J Med."},{"issue":"3","key":"269_CR20","doi-asserted-by":"crossref","first-page":"382","DOI":"10.3109\/s10165-011-0534-4","volume":"22","author":"N Miyasaka","year":"2012","unstructured":"Miyasaka N, Hara M, Koike T, Saito E, Yamada M, Tanaka Y. Effects of intravenous immunoglobulin therapy in Japanese patients with polymyositis and dermatomyositis resistant to corticosteroids: a randomized double-blind placebo-controlled trial. Mod Rheumatol. 2012;22(3):382\u201393.","journal-title":"Mod Rheumatol."},{"issue":"1","key":"269_CR21","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jaad.2008.02.043","volume":"59","author":"LJ Iorizzo 3rd","year":"2008","unstructured":"Iorizzo LJ 3rd, Jorizzo JL. The treatment and prognosis of dermatomyositis: an updated review. J Am Acad Dermatol. 2008;59(1):99\u2013112.","journal-title":"J Am Acad Dermatol."},{"key":"269_CR22","unstructured":"Thai Working Group on Health Technology Assessment Guidelines in Thailand. Health Technology Assessment Guideline. J Med Assoc Thai. 2008;91(suppl 2):S1\u201388."},{"issue":"Suppl 11","key":"269_CR23","doi-asserted-by":"crossref","first-page":"S118","DOI":"10.1002\/acr.20532","volume":"63","author":"LG Rider","year":"2011","unstructured":"Rider LG, Werth VP, Huber AM, et al. Measures for adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis. Arthritis Care Res (Hoboken). 2011;63(Suppl 11):S118\u201357.","journal-title":"Arthritis Care Res (Hoboken)."},{"issue":"12","key":"269_CR24","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1002\/(SICI)1097-4598(199812)21:12<1668::AID-MUS7>3.0.CO;2-#","volume":"21","author":"BA Phillips","year":"1998","unstructured":"Phillips BA, Zilko P, Garlepp MJ, Mastaglia FL. Frequency of relapses in patients with polymyositis and dermatomyositis. Muscle Nerve. 1998;21(12):1668\u201372.","journal-title":"Muscle Nerve."},{"key":"269_CR25","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-540-79313-7","volume-title":"Dermatomyositis: advances in recognition, understanding and management","author":"LA Dourmishev","year":"2009","unstructured":"Dourmishev LA, Dourmishev AL. Dermatomyositis: advances in recognition, understanding and management. 1st ed. Berlin: Springer; 2009.","edition":"1"},{"issue":"19","key":"269_CR26","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1001\/jama.291.19.2367","volume":"291","author":"MC Dalakas","year":"2004","unstructured":"Dalakas MC. Intravenous immunoglobulin in autoimmune neuromuscular diseases. JAMA. 2004;291(19):2367\u201375.","journal-title":"JAMA."},{"issue":"4","key":"269_CR27","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.intimp.2005.11.016","volume":"6","author":"MC Dalakas","year":"2006","unstructured":"Dalakas MC. The role of high-dose immune globulin intravenous in the treatment of dermatomyositis. Int Immunopharmacol. 2006;6(4):550\u20136.","journal-title":"Int Immunopharmacol."},{"issue":"5","key":"269_CR28","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s10067-012-1940-5","volume":"31","author":"DX Wang","year":"2012","unstructured":"Wang DX, Shu XM, Tian XL, et al. Intravenous immunoglobulin therapy in adult patients with polymyositis\/dermatomyositis: a systematic literature review. Clin Rheumatol. 2012;31(5):801\u20136.","journal-title":"Clin Rheumatol."},{"issue":"5","key":"269_CR29","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1002\/mus.21433","volume":"40","author":"PD Donofrio","year":"2009","unstructured":"Donofrio PD, Berger A, Brannagan TH 3rd, et al. Consensus statement: the use of intravenous immunoglobulin in the treatment of neuromuscular conditions report of the AANEM ad hoc committee. Muscle Nerve. 2009;40(5):890\u2013900.","journal-title":"Muscle Nerve."},{"issue":"2","key":"269_CR30","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1080\/030097400750001897","volume":"29","author":"J Vencovsk\u00fd","year":"2000","unstructured":"Vencovsk\u00fd J, Jarosov\u00e1 K, Mach\u00e1cek S, Stud\u00fdnkov\u00e1 J, Kafkov\u00e1 J, Bart\u016fnkov\u00e1 J. Cyclosporine A versus methotrexate in the treatment of polymyositis and dermatomyositis. Scand J Rheumatol. 2000;29(2):95\u2013102.","journal-title":"Scand J Rheumatol."},{"issue":"1","key":"269_CR31","first-page":"50","volume":"23","author":"A Ponyi","year":"2005","unstructured":"Ponyi A, Constantin T, Balogh Z, et al. Disease course, frequency of relapses and survival of 73 patients with juvenile or adult dermatomyositis. Clin Exp Rheumatol. 2005;23(1):50\u20136.","journal-title":"Clin Exp Rheumatol."},{"key":"269_CR32","unstructured":"Health Information Group. Public Health Statistics A.D.2010. Bangkok: Bureau of Policy and Strategy, Ministry of Public Health (Thailand). Available from: http:\/\/bps.ops.moph.go.th\/Healthinformation\/statistic53\/statistic53.pdf . Accessed 4 Mar 2015."},{"issue":"6","key":"269_CR33","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1111\/j.1365-2133.2011.10595.x","volume":"165","author":"CF Kuo","year":"2011","unstructured":"Kuo CF, See LC, Yu KH, et al. Incidence, cancer risk and mortality of dermatomyositis and polymyositis in Taiwan: a nationwide population study. Br J Dermatol. 2011;165(6):1273\u20139.","journal-title":"Br J Dermatol."},{"issue":"2","key":"269_CR34","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s10067-005-1164-z","volume":"25","author":"A Airio","year":"2006","unstructured":"Airio A, Kautiainen H, Hakala M. Prognosis and mortality of polymyositis and dermatomyositis patients. Clin Rheumatol. 2006;25(2):234\u20139.","journal-title":"Clin Rheumatol."},{"key":"269_CR35","unstructured":"Tongsiri S. The Thai population based preference scores for EQ-5D health states: Ministry of Public Health; 2009."},{"key":"269_CR36","volume-title":"Economic evaluations in health care: merging theory with practice","author":"W Brouwer","year":"2001","unstructured":"Brouwer W, Rutten F, Koopmanschap M. Costing in Economic Evaluations. In: Drummond M, McGuire A, editors. Economic evaluations in health care: merging theory with practice. New York: Oxford University Press; 2001."},{"key":"269_CR37","unstructured":"Bank of Thailand. EC_EI_027: Thailand\u2019s Macro Economic Indicators. Available from: http:\/\/www2.bot.or.th\/statistics\/ReportPage.aspx?reportID=409&language=eng . Accessed 5 July 2014."},{"key":"269_CR38","volume-title":"Unit cost manual for hospital","year":"2011","unstructured":"Tienjaruwattana W, Sakulpanich T, Pongpattarachai D, Chiangchaisakulthai K, editors. Unit cost manual for hospital. 1st ed. Bangkok: MUCC, Ministry of Public Health Network of Unit Cost; 2011.","edition":"1"},{"key":"269_CR39","unstructured":"Drug Medical Supply and Information Center (DMSIC). Reference price database of the Drugs and Medical Supplies Information Center (DMSIC). Bangkok: Ministry of Public Health (Thailand). Available from: http:\/\/dmsic.moph.go.th\/dmsic\/index.php?p=1&type=3&s=3&id=drug_normal . Accessed 4 Mar 2015."},{"issue":"supp l5","key":"269_CR40","first-page":"S127","volume":"97","author":"A Riewpaiboon","year":"2014","unstructured":"Riewpaiboon A. Standard cost lists for health economic evaluation in Thailand. J Med Assoc Thai. 2014;97(supp l5):S127\u201334.","journal-title":"J Med Assoc Thai."},{"key":"269_CR41","unstructured":"Thavorncharoensap M, Leelahavarong M, Doungthipsirkul S, Sompitak S, Teerawattananon Y. Assessing a societal value for a ceiling threshold in Thailand. Nonthaburi, Thailand: Health Intervention and Technology Assessment Program (HITAP), Ministry of Public Health; 2013."},{"key":"269_CR42","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780198526629.001.0001","volume-title":"Decision modelling for health economic evaluation","author":"A Briggs","year":"2006","unstructured":"Briggs A, Sculpher M, Claxton K. Decision modelling for health economic evaluation. Oxford: Oxford University Press; 2006."},{"issue":"6","key":"269_CR43","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/1529-0131(200012)13:6<360::AID-ART5>3.0.CO;2-Q","volume":"13","author":"MS Klein-Gitelman","year":"2000","unstructured":"Klein-Gitelman MS, Waters T, Pachman LM. The economic impact of intermittent high-dose intravenous versus oral corticosteroid treatment of juvenile dermatomyositis. Arthritis Care Res. 2000;13(6):360\u20138.","journal-title":"Arthritis Care Res."},{"issue":"5","key":"269_CR44","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1007\/s00415-014-7313-z","volume":"261","author":"J Vlekkert van de","year":"2014","unstructured":"van de Vlekkert J, Hoogendijk JE, de Visser M. Long-term follow-up of 62 patients with myositis. J Neurol. 2014;261(5):992\u20138.","journal-title":"J Neurol."}],"container-title":["PharmacoEconomics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40273-015-0269-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40273-015-0269-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40273-015-0269-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T20:42:12Z","timestamp":1717792932000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40273-015-0269-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,14]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["269"],"URL":"https:\/\/doi.org\/10.1007\/s40273-015-0269-8","relation":{},"ISSN":["1170-7690","1179-2027"],"issn-type":[{"value":"1170-7690","type":"print"},{"value":"1179-2027","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,14]]}}}